Formulation and Evaluation of Oral Dispersion Tablet of Telmisartan Mahesh PG1,*, Raman S.G.2 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai-600117 2Department of Chemistry, School of Pharmacy, Sri Balaji Vidyapeeth Deemed to be University, Puducherry, India *Corresponding Author E-mail: pgmahesh83@gmail.com
Online published on 10 August, 2020. Abstract Aim Telmisartan is used for treatment of a number of infections including infection of joints and bones, gastroenteritis, malignant obits external, respiratory tract infections, cellulites, urinary tract infections, anthrax, skin structural infections, typhoid fever and it also used in treatment of community acquired pneumonia, chronic bacterial prostitis, nosocomial pneumonia etc. Objective Difficulty in swallowing (dysphasia) is a common problem of all age groups, especially the elderly and pediatrics, because of physiological changes associated with these groups. Conclusion In the present work it has been observed from all formulations of Pre compression and post compression studies were given within the limit of values. The in vitro dissolution data, F1 (combination of different super disintegrates) formulation was found that the drug release is best and the cumulative % of drug release was 90.88% respectively, when compared to other formulation. Top Keywords Gastroenteritis, malignant obits external, dysphasia. Top |